Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for media industry professionals · Sunday, June 23, 2024 · 722,255,637 Articles · 3+ Million Readers

India Contrast Media Market Expected to Surpass US$ 220.8 Million by 2032, Growing at a 4.6% CAGR

CHICAGO, UNITED STATES, May 27, 2024 /EINPresswire.com/ -- The 𝐈𝐧𝐝𝐢𝐚 𝐂𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐌𝐞𝐝𝐢𝐚 𝐌𝐚𝐫𝐤𝐞𝐭, which was valued at 𝐔𝐒$ 𝟏𝟒𝟕.𝟑 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟐, is anticipated to exceed 𝐔𝐒$ 𝟐𝟐𝟎.𝟖 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, exhibiting a robust Compound Annual Growth Rate (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟒.𝟔% during the forecast period from 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟐.

𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:- https://www.astuteanalytica.com/request-sample/india-contrast-media-market

This significant growth is driven by increasing advancements in medical imaging technologies, rising prevalence of chronic diseases, and an expanding geriatric population. The enhanced adoption of contrast media in diagnostic imaging modalities such as MRI, CT scans, and X-rays has further accelerated market expansion.

Market analysts attribute this positive trend to heightened awareness regarding early disease detection and diagnosis, improved healthcare infrastructure, and government initiatives aimed at enhancing healthcare services across the country. Furthermore, the ongoing developments in contrast agents, offering higher precision and safety, are expected to fuel market growth.

As healthcare providers and diagnostic centers continue to integrate advanced imaging technologies, the demand for contrast media is set to rise. Key industry players are also focusing on strategic collaborations and product innovations to cater to the evolving needs of the market.

Allex Medical Systems
Aurobindo Pharma Limited
Bayer AG
Bracco Imaging S.p.A.
Cadila Healthcare Limited
Cipla Limited
Congruent Pharmachem Private Limited
GE Healthcare
Guerbet Group
J.B. Chemicals & Pharmaceuticals Ltd.
Jodas Expoim Pvt. Ltd.
Lifecura Pharma
Lupin Limited
Medicon Lifesciences
Sun Pharmaceutical Industries Ltd.
Torrent Pharmaceuticals Ltd.
Other Prominent Players

𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭, 𝐩𝐥𝐞𝐚𝐬𝐞 𝐯𝐢𝐬𝐢𝐭:- https://www.astuteanalytica.com/industry-report/india-contrast-media-market

Market Segmentation Overview:

By Category

Low osmolality contrast media (LOCM)
High osmolality contrast media (HOCM)
By Type

Iodinated
Gadolinium Based
Others
By Modality

X-ray/Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Macrocyclic
Linear
By Application

Oncology
Lung Cancer
Breast Cancer
Others
Cardiology
Neurology
Inflammations
Others

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭@- https://www.astuteanalytica.com/request-sample/india-contrast-media-market

𝐀𝐛𝐨𝐮𝐭 𝐀𝐬𝐭𝐮𝐭𝐞 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

Aamir Beg
Astute Analytica
+1 888-429-6757
email us here
Visit us on social media:
Twitter
LinkedIn

Powered by EIN Presswire
Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release